PlainRecalls
FDA Drug Moderate Class II Terminated

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

Reported: June 26, 2024 Initiated: May 30, 2024 #D-0559-2024

Product Description

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

Reason for Recall

Failed Content Uniformity Specifications

Details

Units Affected
3,552 bottles
Distribution
Nationwide in the US
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 3,552 bottles.
Why was this product recalled?
Failed Content Uniformity Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on June 26, 2024. Severity: Moderate. Recall number: D-0559-2024.